Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 820

Sort by

Sort Order Select

Journal Articles

β-Cell Glucose Sensitivity to Assess Changes in β-Cell Function in Recent-Onset Stage 3 Type 1 Diabetes

Stephen E. Gitelman, Carmella Evans-Molina, Annamaria Guolo, Andrea Mari, Ele Ferrannini

Diabetes 2023;72(9):1289–1296

https://doi.org/10.2337/db23-0196

Published: 27 June 2023

View article titled, β-Cell Glucose Sensitivity to Assess Changes in β-Cell Function in Recent-Onset Stage 3 Type 1 Diabetes

Meeting Abstracts

761-P: Effect of Orforglipron vs. Placebo and Dulaglutide on Glycemic Control and Body Weight in Patients with Type 2 Diabetes

JUAN P. FRIAS, STANLEY H. HSIA, SARAH EYDE, RONG LIU, XIAOSU MA, MANIGE KONIG, CHRISTOF M. KAZDA, EDWARD J. PRATT, KIEREN J. MATHER, AXEL HAUPT, DEBORAH A. ROBINS

Diabetes 2023;72(Supplement_1):761-P

https://doi.org/10.2337/db23-761-P

Published: 25 June 2023

View article titled, 761-P: Effect of Orforglipron vs. Placebo and Dulaglutide on Glycemic Control and Body Weight in Patients with Type 2 Diabetes

Meeting Abstracts

1800-PUB: The Long-Term Effect of Glucagon-Like Peptide 1 Receptor Agonists on Glycemic Control Is Predominantly Related to Weight Loss

MARWA AL-BADRI, SHILTON E. DHAVER, TAREQ SALAH, KARIM KIBAA, ABDELRAHMAN KHATER, RYAN MCCARRAGHER, LILY DEMATTOS, FATIMAH AL-ROOMI, OSAMA HAMDY

Diabetes 2023;72(Supplement_1):1800-PUB

https://doi.org/10.2337/db23-1800-PUB

Published: 23 June 2023

View article titled, 1800-PUB: The Long-Term Effect of Glucagon-Like Peptide 1 Receptor Agonists on Glycemic Control Is Predominantly Related to Weight Loss

Meeting Abstracts

1826-PUB: Efficacy of Digital Diabetes Care Program in India—Retrospective Analysis

NAVNEET AGRAWAL, ADITYA PANJABI, PRASHANT K. DIXIT, BHEEMARAYA D

Diabetes 2023;72(Supplement_1):1826-PUB

https://doi.org/10.2337/db23-1826-PUB

Published: 23 June 2023

View article titled, 1826-PUB: Efficacy of Digital Diabetes Care Program in India—Retrospective Analysis

Meeting Abstracts

1827-PUB: Multidisciplinary Patient-Centered Care Delivered Remotely Improves Glycemic Outcomes and Patient Reported Outcomes

NOGA MINSKY, GENYA AHARON-HANANEL, AMNA JABARIN, LIAT ARNON, NICOLE MOROZOV, DANIA HALPERIN, MOSHE SHALOM, ELIZABETH TARSHISH, TATYANA KOLOBOV, AMIR TIROSH, ORLY TAMIR

Diabetes 2023;72(Supplement_1):1827-PUB

https://doi.org/10.2337/db23-1827-PUB

Published: 23 June 2023

View article titled, 1827-PUB: Multidisciplinary Patient-Centered Care Delivered Remotely Improves Glycemic Outcomes and Patient Reported Outcomes

Meeting Abstracts

178-OR: Better Glycemic Control with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Insulin-Naïve Type 2 Diabetes (ONWARDS 3)

ILDIKO LINGVAY, MARISSE ASONG, CYRUS DESOUZA, PIERRE GOURDY, SOUMITRA KAR, ANDRE G. VIANNA, TINA VILSBØLL, SIRI M. VINTHER, YIMING MU

Diabetes 2023;72(Supplement_1):178-OR

https://doi.org/10.2337/db23-178-OR

Published: 23 June 2023

View article titled, 178-OR: Better Glycemic Control with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Insulin-Naïve Type 2 Diabetes (ONWARDS 3)

Meeting Abstracts

968-P: Real-World Comparison of Younger and Older Cohorts Using the Bigfoot Unity System for Six Months

SARAH VAUGHAN, JOHN TILLMAN, BYRON P. OLSON, F. NAUREEN SHEIKH, JAMES K. MALONE

Diabetes 2023;72(Supplement_1):968-P

https://doi.org/10.2337/db23-968-P

Published: 20 June 2023

View article titled, 968-P: Real-World Comparison of Younger and Older Cohorts Using the Bigfoot Unity System for Six Months

Meeting Abstracts

1555-P: Novel Imaging Platform Highlights the Disconnect between ß-Cell Mass and Glucose Control in the Onset of Type 1 Diabetes

CORENTIN CRAS-MÉNEUR, RANDY J. SEELEY, PETER ARVAN

Diabetes 2023;72(Supplement_1):1555-P

https://doi.org/10.2337/db23-1555-P

Published: 20 June 2023

View article titled, 1555-P: Novel Imaging Platform Highlights the Disconnect between ß-Cell Mass and Glucose Control in the Onset of Type 1 Diabetes

Meeting Abstracts

1551-P: Association between Short-Term Postprandial C-Peptide Index Recovery during Hospitalization and Future Glycemic Control in Patients with Type 2 Diabetes

ASAKO ENKAKU, DAISUKE CHUJO, MIKI KAMIGISHI, SHINYA INAGAWA, WAKA SAKAI, SHINNOSUKE MATSUKOSHI, AKIKO TAKIKAWA, SHIHO FUJISAKA, KAZUYUKI TOBE

Diabetes 2023;72(Supplement_1):1551-P

https://doi.org/10.2337/db23-1551-P

Published: 20 June 2023

View article titled, 1551-P: Association between Short-Term Postprandial C-Peptide Index Recovery during Hospitalization and Future Glycemic Control in Patients with Type 2 Diabetes

Meeting Abstracts

1088-P: Glycemic Control Trajectories among Individuals with Gestational Diabetes Are Associated with Risk of Childhood Obesity in the Offspring

RANA F. CHEHAB, ASSIAMIRA FERRARA, MARA GREENBERG, CATHERINE LEE, AMANDA NGO, YEYI ZHU

Diabetes 2023;72(Supplement_1):1088-P

https://doi.org/10.2337/db23-1088-P

Published: 20 June 2023

View article titled, 1088-P: Glycemic Control Trajectories among Individuals with Gestational Diabetes Are Associated with Risk of Childhood Obesity in the Offspring

Meeting Abstracts

1700-P: Optimizing Data Cleaning Methods for Remotely Collected Electronic Weight Measurements

SAHER DAREDIA, BRIDGETTE P. SMITH, HILLARY SERRATO BANDERA, ANDREA MILLMAN, CHARLES QUESENBERRY, ASSIAMIRA FERRARA, SUSAN D. BROWN

Diabetes 2023;72(Supplement_1):1700-P

https://doi.org/10.2337/db23-1700-P

Published: 20 June 2023

View article titled, 1700-P: Optimizing Data Cleaning Methods for Remotely Collected Electronic Weight Measurements

Meeting Abstracts

121-LB: Effect of Using the mySugr App on Glycemic Control in T1D patients—A Real-World Analysis from Mexico

CRISTINA VULCANO, HEATHER MIKULSKI, MICHAEL MITTER, BERNHARD RUCH

Diabetes 2023;72(Supplement_1):121-LB

https://doi.org/10.2337/db23-121-LB

Published: 20 June 2023

View article titled, 121-LB: Effect of Using the mySugr App on Glycemic Control in T1D patients—A Real-World Analysis from Mexico

Meeting Abstracts

169-LB: Neuropsychological Consultation and Glycemic Control in Pediatric Patients

JUANA E. GONZALEZ, CHERYL R. STEIN, JENIECE ILKOWITZ, SARAH POWELL, MARY PAT GALLAGHER

Diabetes 2023;72(Supplement_1):169-LB

https://doi.org/10.2337/db23-169-LB

Published: 20 June 2023

View article titled, 169-LB: Neuropsychological Consultation and Glycemic Control in Pediatric Patients

Meeting Abstracts

1126-P: Smart Insulin Pens—A Randomized, Crossover Pilot Trial Assessing Glycemic Control and Diabetes-Related Burdens in Adolescents and Emerging Adults with Diabetes

SARAH JACKSON, SEEMA KUMAR, ALAA AL NOFAL, ROLAND HENTZ, SIOBHAN PITTOCK, ANA CREO

Diabetes 2023;72(Supplement_1):1126-P

https://doi.org/10.2337/db23-1126-P

Published: 20 June 2023

View article titled, 1126-P: Smart Insulin Pens—A Randomized, Crossover Pilot Trial Assessing Glycemic Control and Diabetes-Related Burdens in Adolescents and Emerging Adults with Diabetes

Meeting Abstracts

947-P: Glycemic Control Utilizing Continuous Glucose Monitoring vs. Point-of-Care Testing in Older Adults with Type 2 Diabetes in Long-Term Care Facilities

THAER IDREES, IRIS A. CASTRO-REVOREDO, MONICA D. GAVALLER, HYUNGSEOK OH, ZOHYRA ZABALA, EMMELIN M. MORENO, BOBAK MOAZZAMI, RODOLFO J. GALINDO, ELENA CABB, THEODORE M. JOHNSON, LIMIN PENG, GUILLERMO UMPIERREZ

Diabetes 2023;72(Supplement_1):947-P

https://doi.org/10.2337/db23-947-P

Published: 20 June 2023

View article titled, 947-P: Glycemic Control Utilizing Continuous Glucose Monitoring vs. Point-of-Care Testing in Older Adults with Type 2 Diabetes in Long-Term Care Facilities

Meeting Abstracts

945-P: Effect of Real-Time Continuous Glucose Monitoring vs. Flash Glucose Monitoring on Glycemic Control and Glycemic Variability in Patients with Type 1 Diabetes—A Systematic Review and Meta-analysis

DANRUI CHEN, ZHIGU LIU, BEISI LIN, YANLING YANG, DAIZHI YANG, JINHUA YAN, WEN XU

Diabetes 2023;72(Supplement_1):945-P

https://doi.org/10.2337/db23-945-P

Published: 20 June 2023

View article titled, 945-P: Effect of Real-Time Continuous Glucose Monitoring vs. Flash Glucose Monitoring on Glycemic Control and Glycemic Variability in Patients with Type 1 Diabetes—A Systematic Review and Meta-analysis

Meeting Abstracts

944-P: Continuous Glucose Monitoring (CGM) Sampling Duration to Estimate Long-Term Glycemic Control in Adults with T2D Not Using Insulin

SAM BACON, NELS THOMPSON, DAVID FERRELL, JASON FUNG

Diabetes 2023;72(Supplement_1):944-P

https://doi.org/10.2337/db23-944-P

Published: 20 June 2023

View article titled, 944-P: Continuous Glucose Monitoring (CGM) Sampling Duration to Estimate Long-Term Glycemic Control in Adults with T2D Not Using Insulin

Meeting Abstracts

943-P: Improved Glycemic Outcomes after One Year among Level 2 Members

SAM BACON, NELS THOMPSON, DAVID FERRELL, JASON FUNG

Diabetes 2023;72(Supplement_1):943-P

https://doi.org/10.2337/db23-943-P

Published: 20 June 2023

View article titled, 943-P: Improved Glycemic Outcomes after One Year among Level 2 Members

Meeting Abstracts

929-P: Adaptive Therapy Settings—Qualitative Insights from People with Type 1 Diabetes Using Multiple Daily Injections Transitioning to an Automated System

STEPHANIE HABIF, ELAINE SCHERTZ, ALEX TRAHAN, ALEXANDRA CONSTANTIN, ALEX WHEATCROFT, KIRSTIN N. WHITE, NICOLE J. PIQUETTE, KAREN CARMELO, RAVID KATCHALSKI, JORDAN E. PINSKER, LAUREL H. MESSER

Diabetes 2023;72(Supplement_1):929-P

https://doi.org/10.2337/db23-929-P

Published: 20 June 2023

View article titled, 929-P: Adaptive Therapy Settings—Qualitative Insights from People with Type 1 Diabetes Using Multiple Daily Injections Transitioning to an Automated System

Meeting Abstracts

927-P: Robustness of MiniMed Advanced Hybrid Closed-Loop (AHCL) Algorithm on a Spectrum of Glycemic Control

JOHN SHIN, ZHENG DAI, FANG NIU

Diabetes 2023;72(Supplement_1):927-P

https://doi.org/10.2337/db23-927-P

Published: 20 June 2023

View article titled, 927-P: Robustness of MiniMed Advanced Hybrid Closed-Loop (AHCL) Algorithm on a Spectrum of Glycemic Control

NARROW

β-Cell Glucose Sensitivity to Assess Changes in β-Cell Function in Recent-Onset Stage 3 Type 1 Diabetes

761-P: Effect of Orforglipron vs. Placebo and Dulaglutide on Glycemic Control and Body Weight in Patients with Type 2 Diabetes

1800-PUB: The Long-Term Effect of Glucagon-Like Peptide 1 Receptor Agonists on Glycemic Control Is Predominantly Related to Weight Loss

1826-PUB: Efficacy of Digital Diabetes Care Program in India—Retrospective Analysis

1827-PUB: Multidisciplinary Patient-Centered Care Delivered Remotely Improves Glycemic Outcomes and Patient Reported Outcomes

178-OR: Better Glycemic Control with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Insulin-Naïve Type 2 Diabetes (ONWARDS 3)

968-P: Real-World Comparison of Younger and Older Cohorts Using the Bigfoot Unity System for Six Months

1555-P: Novel Imaging Platform Highlights the Disconnect between ß-Cell Mass and Glucose Control in the Onset of Type 1 Diabetes

1551-P: Association between Short-Term Postprandial C-Peptide Index Recovery during Hospitalization and Future Glycemic Control in Patients with Type 2 Diabetes

1088-P: Glycemic Control Trajectories among Individuals with Gestational Diabetes Are Associated with Risk of Childhood Obesity in the Offspring

1700-P: Optimizing Data Cleaning Methods for Remotely Collected Electronic Weight Measurements

121-LB: Effect of Using the mySugr App on Glycemic Control in T1D patients—A Real-World Analysis from Mexico

169-LB: Neuropsychological Consultation and Glycemic Control in Pediatric Patients

1126-P: Smart Insulin Pens—A Randomized, Crossover Pilot Trial Assessing Glycemic Control and Diabetes-Related Burdens in Adolescents and Emerging Adults with Diabetes

947-P: Glycemic Control Utilizing Continuous Glucose Monitoring vs. Point-of-Care Testing in Older Adults with Type 2 Diabetes in Long-Term Care Facilities

945-P: Effect of Real-Time Continuous Glucose Monitoring vs. Flash Glucose Monitoring on Glycemic Control and Glycemic Variability in Patients with Type 1 Diabetes—A Systematic Review and Meta-analysis

944-P: Continuous Glucose Monitoring (CGM) Sampling Duration to Estimate Long-Term Glycemic Control in Adults with T2D Not Using Insulin

943-P: Improved Glycemic Outcomes after One Year among Level 2 Members

929-P: Adaptive Therapy Settings—Qualitative Insights from People with Type 1 Diabetes Using Multiple Daily Injections Transitioning to an Automated System

927-P: Robustness of MiniMed Advanced Hybrid Closed-Loop (AHCL) Algorithm on a Spectrum of Glycemic Control

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only